Endpoints News· @endpts · X·· 2026-10-15AI 评分33
AI 导读
Paul Stoffels并未放弃Galapagos的细胞疗法。他的新生物技术公司Armed Cell已收购了该临床前CAR-T项目。https://endpoints.news/paul-stoffels-to-bring-galapagos-cell-therapies-back-to-life/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Paul Stoffels isn’t giving up on Galapagos’ cell therapies. His new biotech, Armed Cell, has bought the preclinical CAR-T work. https://endpoints.news/paul-stoffels-to-bring-galapagos-cell-therapies-back-to-life/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com